Neurophysiologic investigation of somatosensory dysfunction in Autism Spectrum Disorders

自闭症谱系障碍体感功能障碍的神经生理学研究

• 批准号: 10057023
• 负责人: Alexander Rotenberg
• 金额: $ 50.25万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-05-11 至 2023-05-10
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10057023
• 关键词: Address; Age; Animals; Anxiety; Area; Attention; Behavior; Behavioral; Biological Markers; Brain region; Brain-Derived Neurotrophic Factor; Budgets; Cerebrum; Congenital neurologic anomalies; Contralateral; Control Groups; Coupled; Coupling; Data; Detection; Development; Diagnosis; Diffuse; Disease model; Electromyography; Electrophysiology (science); Exhibits; Fiber; Functional disorder; Future; Genes; Genetic Variation; Health; Human; Hypersensitivity; Impairment; Individual; Intervention; Investigation; Knowledge; Measurement; Measures; Mechanics; Mediating; Motor; Motor Cortex; Motor Evoked Potentials; Motor output; Mus; Neuraxis; Neurologic; Neuropsychology; Outcome; Participant; Pathologic; Pathway interactions; Patients; Peripheral; Peripheral Nerves; Peripheral Nervous System; Pharmacology; Physiologic pulse; Physiological; Population; Protocols documentation; Publishing; Reporting; Research; Risk; Saliva; Sampling; Sensory; Series; Signal Pathway; Signal Transduction; Single Nucleotide Polymorphism; Skin; Social Behavior; Socialization; Somatosensory Disorders; Spinal Cord; Spinal Ganglia; Standardization; Stimulus; Surface; Symptoms; Synaptic plasticity; Tactile; Testing; Therapeutic; Therapeutic Trials; Transcranial magnetic stimulation; United States Food and Drug Administration; Visit; Work; autism spectrum disorder; autistic; base; behavioral phenotyping; brain dysfunction; cognitive ability; cohort; cost; experience; experimental study; improved; indexing; insight; median nerve; neurophysiology; novel; novel therapeutic intervention; pre-clinical; predicting response; prepulse inhibition; reduce symptoms; response; restoration; screening; sensory integration; sensory stimulus; somatosensory; tool; young adult

Project Summary Autism spectrum disorders (ASD) are the cause of large health-related and economical costs in the U.S. Thus, interventions that relieve symptoms for ASD patients are urgently needed. There are currently no treatments approved by the Food and Drug Administration for ASD. The development of novel therapeutic interventions will require early and reliable biomarkers and improved understanding of the underlying ASD pathophysiology. Most of the research on ASD so far has focused on mechanisms and circuits specific to the central nervous system with little attention to the contributions of abnormal signaling in the peripheral nervous system and spinal cord to the pathophysiology and core symptoms of ASD. Critically, most ASD patients exhibit enhanced responses to sensory stimuli, including tactile stimuli. Moreover, the degree of tactile hypersensitivity is strongly correlated with increased anxiety behaviors and social-behavior deficits observed in ASD. However, there are currently no neurophysiologic indices of tactile hypersensitivity and its contribution to dysfunction of brain networks. In cohorts of 40 ASD young adults, and 40 neurotypical young adults, we will compare the responses to paired associative stimulation (PAS) of the median nerve and the primary motor cortex between individuals with ASD and the control group – this will serve as a primary measure of the lasting effects on cortical cuntion that aberrant (pathologically heightened) peripheral signaling may have in ASD. Second, we will examine the correlation between the extent of abnormal PAS response in the ASD group and the degree of tactile hypersensitivity as objectively quantified by tactile prepulse inhibition (PPI) and mechanical detection threshold with von Frey fibers. Third, we will test the contribution of the common Val66Met single-nucleotide polymorphism (SNP) in the brain-derived neurotrophic factor (BDNF) gene to PAS measures. Each participant will undergo 4 visits, including two visits for quantitative tactile assessments and two visits for assessment of PAS-induced plasticity. All participants will undergo baseline assessment, including detailed screening, physical/neurological exam, neuropsychological assessment, and assessment of saliva samples for the BDNF SNP to explore predictors of PAS response. The proposed studies will be the first to validate well-formulated hypotheses from animal ASD research with PAS measures of tactile hypersensitivity. Favorable results from proposed experiments will validate standardized tools as biomarkers of tactile hypersensitivity in ASD and will provide measures of target engagement in future therapeutic trials aimed at improving tactile hypersensitivity and associated anxiety and social behavior deficits among ASD patients.

项目摘要 因此 急需急需ASD院子的症状的干预措施。 由食品和药物管理局批准的ASD。 将需要早期可靠的生物标志物，并提高对基础ASD病理生理学的理解。 大多数CEAR都集中在 系统几乎无法获得外周神经系统中异常信号传导的贡献 ASD的病理生理学和核心症状。 对感官刺激的反应，包括触觉刺激。 但是，与ASD中观察到的焦虑行为和社会行为缺陷密切相关。 目前没有触觉超敏反应的神经生理指标，并且是对功能障碍的贡献 大脑网络。 在40名ASD年轻人和40名神经型年轻人的队列中，我们将比较对配对的反应 ASD患者之间正中神经和主要运动皮层的联想刺激（PA） 对照组 - 这将作为对皮质c的持久影响的主要衡量， 异常（病理高度）外周信号传导可能在ASD中。 ASD组异常PAS响应的程度与触觉程度之间的相关性 超敏反应是通过触觉预硫次（PPI）和机械检测阈值对客观量化的 第三，我们将测试普通Val66met单核苷酸的贡献 脑衍生的神经营养因子（BDNF）基因的多态性（SNP）至PAS测量。 每个参与者将进行4次访问，涉及两次访问定量触觉评估，并进行两次访问 评估PAS诱导的可塑性。 筛查，身体/神经检查，神经心理学评估和唾液样本评估 BDNF SNP探索PAS响应的预测指标。 支持的研究将是第一个通过与动物ASD研究验证良好成熟的假设的研究。 PAS的触觉超敏反应。 标准化工具作为ASD触觉超敏反应的生物标志物将提供目标的衡量 参与未来的治疗试验，旨在改善触觉超敏性超敏焦虑焦虑 ASD患者的社会行为缺陷。